205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.56%
Some net income increase while MRVL is negative at -5578.64%. John Neff would see a short-term edge over the struggling competitor.
-2.81%
Both reduce yoy D&A, with MRVL at -4.82%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-345.83%
Negative yoy deferred tax while MRVL stands at 61.11%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
5.56%
SBC growth well above MRVL's 10.39%. Michael Burry would flag major dilution risk vs. competitor’s approach.
101.29%
Less working capital growth vs. MRVL's 3946.30%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
24.00%
AR growth while MRVL is negative at -188.08%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
37.72%
Inventory shrinking or stable vs. MRVL's 141.20%, indicating lean supply management. David Dodd would confirm no demand shortfall.
137.50%
A yoy AP increase while MRVL is negative at -130.17%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
177.03%
Lower 'other working capital' growth vs. MRVL's 2438.73%. David Dodd would see fewer unexpected short-term demands on cash.
-60.32%
Negative yoy while MRVL is 148.69%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
63.71%
Some CFO growth while MRVL is negative at -54.84%. John Neff would note a short-term liquidity lead over the competitor.
-27.42%
Negative yoy CapEx while MRVL is 10.02%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-396.50%
Negative yoy purchasing while MRVL stands at 55.85%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
34.44%
We have some liquidation growth while MRVL is negative at -10.18%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-4966.67%
We reduce yoy other investing while MRVL is 1402.47%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-88.66%
We reduce yoy invests while MRVL stands at 118.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
183.82%
Issuance growth of 183.82% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
16.35%
We have some buyback growth while MRVL is negative at -764.75%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.